4 hasil untuk "Terry Gernsheimer"
Menampilkan 1–4 · 1,11 detik · RSS
-
Artikel Jurnal
Additional efficacy analysis of avatrombopag phase III data for the treatment of adults with immune thrombocytopenia
Avatrombopag is an oral thrombopoietin receptor agonist (TPO-RA) that was approved in the US in 2019 for treatment of chronic immune thrombocytopenia (ITP). This post hoc analysis of the pivotal phase III study (NCT01438840) of avatrombopag in adult patients with ITP evaluated platelet count…
-
Artikel Jurnal Teks lengkap
Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination
Cases of apparent secondary immune thrombocytopenia (ITP) after SARS-CoV-2 vaccination with both the Pfizer and Moderna versions have been reported and reached public attention. Public alarm was heightened following the death of the first identified patient from an intracranial hemorrhage, which…
-
Artikel Jurnal
Rilzabrutinib placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
Background: Immune thrombocytopenia (ITP) is characterized by primarily autoantibody-mediated platelet destruction and impaired platelet production resulting in thrombocytopenia and an increased risk of bleeding. Other manifestations include increased risk of thrombosis and diminished quality of…
-
Artikel Jurnal
Updated international consensus report on the investigation and management of primary immune thrombocytopenia
Abstract: Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010. A critical review was performed to identify…